Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTransplantation ChimeraStem CellsGraft vs Leukemia EffectBone Marrow TransplantationTreatment OutcomeMyeloablative AgonistsBusulfanTissue DonorsRemission InductionVidarabineRecurrenceGraft vs Tumor EffectHistocompatibility TestingGraft SurvivalLymphocyte TransfusionImmunosuppressive AgentsLeukemia, Myeloid, AcuteMultiple MyelomaLeukemiaRetrospective StudiesCombined Modality TherapyMinor Histocompatibility AntigensSiblingsCord Blood Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsHematopoietic Stem CellsSalvage TherapyDisease-Free SurvivalWhole-Body IrradiationSurvival AnalysisLiver TransplantationLymphocyte DepletionAntilymphocyte SerumMyelodysplastic SyndromesSurvival RateVirus ActivationNeoplasm, ResidualHistocompatibilityPrecursor Cell Lymphoblastic Leukemia-LymphomaMelphalanHLA AntigensChimerismAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesTime FactorsCyclophosphamideHepatic Veno-Occlusive DiseaseMesenchymal Stem Cell TransplantationCytomegalovirusHematopoietic Stem Cell MobilizationAntigensAcute DiseasePrimary MyelofibrosisCell TransplantationAnemia, AplasticKidney TransplantationFollow-Up StudiesHematologic DiseasesAntigens, CD34PrognosisEmbryonic Stem CellsLeukemia, Myeloid, Accelerated PhaseTransplantation ImmunologyCytarabineImmunosuppressionAntibodies, NeoplasmRoseolovirus InfectionsAntineoplastic AgentsBenzamidesAntigens, NeoplasmLeukemia, MyeloidAdult Stem CellsImmunocompromised HostLymphoproliferative DisordersFusion Proteins, bcr-ablAntigens, ViralHodgkin DiseaseAntibodies, MonoclonalReceptors, Purinergic P2X5PyrimidinesGraft RejectionNuclear FamilyLymphoma, Non-HodgkinGranulocyte Colony-Stimulating FactorAntigens, CDGanciclovirInfectionImmunotherapy, AdoptiveCyclosporinePiperazinesFlow Cytometry